4-(3-Phenylsulfonylindol-2-yl)-1-(pyridin-2-yl)piperazinyl-methanones as Potent Inhibitors of both SARS-CoV-2 and HCoV-OC43 Viruses.

MLA

Puxeddu, Michela, et al. “4-(3-Phenylsulfonylindol-2-Yl)-1-(Pyridin-2-Yl)Piperazinyl-Methanones as Potent Inhibitors of Both SARS-CoV-2 and HCoV-OC43 Viruses.” ACS Infectious Diseases, vol. 10, no. 9, Sept. 2024, pp. 3158–75. EBSCOhost, https://doi.org/10.1021/acsinfecdis.4c00108.

APA

Puxeddu, M., Donalisio, M., Bugert, J. J., Corona, A., Cocomazzi, P., Milani, M., Hucke, F., Arduino, I., Esposito, F., Moretti, P., Ortore, M. G., Nalli, M., Manetto, S., Mazzoccanti, G., Bigogno, C., Dondio, G., Sciò, P., Coluccia, A., Fracella, M., … La Regina, G. (2024). 4-(3-Phenylsulfonylindol-2-yl)-1-(pyridin-2-yl)piperazinyl-methanones as Potent Inhibitors of both SARS-CoV-2 and HCoV-OC43 Viruses. ACS Infectious Diseases, 10(9), 3158–3175. https://doi.org/10.1021/acsinfecdis.4c00108

Chicago

Puxeddu, Michela, Manuela Donalisio, Joachim Jakob Bugert, Angela Corona, Paolo Cocomazzi, Mario Milani, Friederike Hucke, et al. 2024. “4-(3-Phenylsulfonylindol-2-Yl)-1-(Pyridin-2-Yl)Piperazinyl-Methanones as Potent Inhibitors of Both SARS-CoV-2 and HCoV-OC43 Viruses.” ACS Infectious Diseases 10 (9): 3158–75. doi:10.1021/acsinfecdis.4c00108.